{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-9818"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-9818","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Effect of Atypical protein kinase C inhibitor (DNDA) on Cell Proliferation and Migration of Lung Cancer Cells","abstract":"Lung cancer is the second most common cancer, and it is the leading cause of cancer death in both men and women. Elevated levels of PKC-ι and FAK are implicated in the progression of lung cancer and involved in cell proliferation, apoptosis, cell survival, and cell migration processes. Lung cancer diagnosis typically occurs in the late stages, which limits the treatment options. Hence, there is a dire need to develop drugs that are effective and safe to treat lung cancers. We used a novel aPKC inhibitor named DNDA (3,4-amino-2,7 napthalene disulfonic acid) to study the role of atypical PKCs (aPKCs) in cell proliferation and migration in lung cancer cell lines. Our study demonstrates that DNDA reduced the cell viability, induced apoptosis and inhibited the migration of A549 lung cancer cells by PKC-ι/FAK ubiquitination via Cbl-b pathway. Hence, DNDA is an excellent candidate to treat lung cancers.","abstract_html":"Lung cancer is the second most common cancer, and it is the leading cause of cancer death in both men and women. Elevated levels of PKC-ι and FAK are implicated in the progression of lung cancer and involved in cell proliferation, apoptosis, cell survival, and cell migration processes. Lung cancer diagnosis typically occurs in the late stages, which limits the treatment options. Hence, there is a dire need to develop drugs that are effective and safe to treat lung cancers. We used a novel aPKC inhibitor named DNDA (3,4-amino-2,7 napthalene disulfonic acid) to study the role of atypical PKCs (aPKCs) in cell proliferation and migration in lung cancer cell lines. Our study demonstrates that DNDA reduced the cell viability, induced apoptosis and inhibited the migration of A549 lung cancer cells by PKC-ι/FAK ubiquitination via Cbl-b pathway. Hence, DNDA is an excellent candidate to treat lung cancers.","abstract_has_math":false,"creators":["Bommareddy, Raja Reddy"],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Mildred Acevedo-Duncan, Ph.D.","Wayne C. Guida, Ph.D.","Jainfeng Cai, Ph.D.","Meera Nanjundan, Ph.D.","Marie Bourgeois, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-11-15T08:00:00Z","date_published":"2019-11-15T08:00:00Z","updated_at":"2026-11-19T08:46:56Z","subjects":["cell viability","apoptosis","ubiquitination","invasion","Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/8621","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/8621","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-9818","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Mildred Acevedo-Duncan, Ph.D.","Wayne C. Guida, Ph.D.","Jainfeng Cai, Ph.D.","Meera Nanjundan, Ph.D.","Marie Bourgeois, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Bommareddy, Raja Reddy"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-11-15T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["cell viability","apoptosis","ubiquitination","invasion","Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/8621"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Lung cancer is the second most common cancer, and it is the leading cause of cancer death in both men and women. Elevated levels of PKC-ι and FAK are implicated in the progression of lung cancer and involved in cell proliferation, apoptosis, cell survival, and cell migration processes. Lung cancer diagnosis typically occurs in the late stages, which limits the treatment options. Hence, there is a dire need to develop drugs that are effective and safe to treat lung cancers. We used a novel aPKC inhibitor named DNDA (3,4-amino-2,7 napthalene disulfonic acid) to study the role of atypical PKCs (aPKCs) in cell proliferation and migration in lung cancer cell lines. Our study demonstrates that DNDA reduced the cell viability, induced apoptosis and inhibited the migration of A549 lung cancer cells by PKC-ι/FAK ubiquitination via Cbl-b pathway. Hence, DNDA is an excellent candidate to treat lung cancers."]},{"key":"dc:title","label":"Title","values":["Effect of Atypical protein kinase C inhibitor (DNDA) on Cell Proliferation and Migration of Lung Cancer Cells"]}]}],"canonical_facts":{"dc:contributor":["Mildred Acevedo-Duncan, Ph.D.","Wayne C. Guida, Ph.D.","Jainfeng Cai, Ph.D.","Meera Nanjundan, Ph.D.","Marie Bourgeois, Ph.D."],"dc:creator":["Bommareddy, Raja Reddy"],"dc:date":["2019-11-15T08:00:00Z"],"dc:description":["Lung cancer is the second most common cancer, and it is the leading cause of cancer death in both men and women. Elevated levels of PKC-ι and FAK are implicated in the progression of lung cancer and involved in cell proliferation, apoptosis, cell survival, and cell migration processes. Lung cancer diagnosis typically occurs in the late stages, which limits the treatment options. Hence, there is a dire need to develop drugs that are effective and safe to treat lung cancers. We used a novel aPKC inhibitor named DNDA (3,4-amino-2,7 napthalene disulfonic acid) to study the role of atypical PKCs (aPKCs) in cell proliferation and migration in lung cancer cell lines. Our study demonstrates that DNDA reduced the cell viability, induced apoptosis and inhibited the migration of A549 lung cancer cells by PKC-ι/FAK ubiquitination via Cbl-b pathway. Hence, DNDA is an excellent candidate to treat lung cancers."],"dc:identifier":["https://digitalcommons.usf.edu/etd/8621"],"dc:subject":["cell viability","apoptosis","ubiquitination","invasion","Chemistry"],"dc:title":["Effect of Atypical protein kinase C inhibitor (DNDA) on Cell Proliferation and Migration of Lung Cancer Cells"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:46:56Z"}